18 January 2021 in Nanoscale Advances
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease that began in 2019 (COVID-19), has been responsible for 1.4 million deaths worldwide as of 13 November 2020. Because at the time of writing no vaccine is yet available, a rapid diagnostic assay is very urgently needed. Herein, we present the development of anti-spike antibody attached gold nanoparticles for the rapid diagnosis of specific COVID-19 viral antigen or virus via a simple colorimetric change observation within a 5 minute time period. For rapid and highly sensitive identification, surface enhanced Raman spectroscopy (SERS) was employed using 4-aminothiophenol as a reporter molecule, which is attached to the gold nanoparticle via an Au–S bond. In the presence of COVID-19 antigen or virus particles, owing to the antigen–antibody interaction, the gold nanoparticles undergo aggregation, changing color from pink to blue, which allows for the determination of the presence of antigen or virus very rapidly by the naked eye, even at concentrations of 1 nanogram (ng) per mL for COVID-19 antigen and 1000 virus particles per mL for SARS-CoV-2 spike protein pseudotyped baculovirus. Importantly, the aggregated gold nanoparticles form “hot spots” to provide very strong SERS signal enhancement from anti-spike antibody and 4-aminothiophenol attached gold nanoparticles via light–matter interactions. Finite-difference time-domain (FDTD) simulation data indicate a 4-orders-of-magnitude Raman enhancement in “hot spot” positions when gold nanoparticles form aggregates. Using a portable Raman analyzer, our reported data demonstrate that our antibody and 4-aminothiophenol attached gold nanoparticle-based SERS probe has the capability to detect COVID-19 antigen even at a concentration of 4 picograms (pg) per mL and virus at a concentration of 18 virus particles per mL within a 5 minute time period. Using HEK293T cells, which express angiotensin-converting enzyme 2 (ACE2), by which SARS-CoV-2 enters human cells, we show that anti-spike antibody attached gold nanoparticles have the capability to inhibit infection by the virus. Our reported data show that antibody attached gold nanoparticles bind to SARS-CoV-2 spike protein, thereby inhibiting the virus from binding to cell receptors, which stops virus infection and spread. It also has the capability to destroy the lipid membrane of the virus.
31 March 2020 in Nanoscale Advances
The emergence of antibiotic-resistant bacteria is the biggest threat to our society. The rapid discovery of drug resistant bacteria is very urgently needed to guide antibiotic treatment development. The current manuscript reports the design of a 2D–0D heterostructure-based surface enhanced Raman spectroscopy (SERS) platform, which has the capability for the rapid identification of the multidrug resistant strain of Salmonella DT104. Details of the synthesis and characterization of the heterostructure SERS platform using a two dimensional (2D) WS2 transition metal dichalcogenide (TMD) and zero dimensional (0D) plasmonic gold nanoparticles (GNPs) have been reported. The current manuscript reveals that the 2D–0D heterostructure-based SERS platform exhibits extremely high Raman enhancement capabilities. Using Rh-6G and 4-ATP probe molecules, we determined that the SERS sensitivity is in the range of ∼10−10 to 10−11 M, several orders of magnitude higher than 2D-TMD on its own (10−3 M) or 0D-GNPs on their own (∼10−6 to 10−7 M). Experimental and theoretical finite-difference time-domain (FDTD) simulation data indicate that the synergistic effect of an electromagnetic mechanism (EM) and a chemical mechanism (CM) on the heterostructure is responsible for the excellent SERS enhancement observed. Notably, the experimental data reported here show that the heterostructure-based SERS has the ability to separate a multidrug resistance strain from a normal strain of Salmonella by monitoring the antibiotic–pathogen interaction within 90 minutes, even at a concentration of 100 CFU mL−1.
16 November 2017 in Journal of Materials Chemistry B
The United Nations (UN) estimates that more than one billion people in this world do not have access to safe drinking water due to microbial hazards and it kills more than 7.6 million children every year via waterborne diseases. Driven by the need for the removal and inactivation of waterborne pathogens in drinking water, we report the chemical design and details of microscopic characterization of a bio-conjugated chitosan attached carbon nanotube based three dimensional (3D) nanoporous architecture, which has the capability for effective separation and complete disinfection of waterborne pathogens from environmental water samples. In the reported design, chitosan, a biodegradable antimicrobial polysaccharide with an architecture-forming ability has been used for the formation of 3D pores as channels for water passage, as well as to increase the permeability on the inner and outer architectures for killing Rotavirus and Shigella waterborne pathogens. On the other hand, due to their large surface area, CNTs have been wrapped by chitosan to enhance the adsorption capability of the architecture for the separation and removal of pathogens from water. The reported data show that the anti-Rotavirus VP7 antibody and LL-37 antimicrobial peptide conjugated chitosan–CNT architecture can be used for efficient separation, identification and 100% eradication of Rotavirus and Shigella waterborne pathogens from water samples of different sources. A detailed mechanism for the separation and inactivation of waterborne pathogens using the bio-conjugated chitosan based 3D architecture has been discussed using microscopic and spectroscopic studies. Reported experimental data demonstrate that the multifunctional bio-conjugated 3D architecture has good potential for use in waterborne pathogen separation and inactivation technology.
26 November 2018 in Nanoscale Advances
Breast tumor heterogeneity was responsible for the death of ∼40 000 women in 2017 in the USA. Triple-negative breast cancers (TNBCs) are very aggressive, and this is the only subgroup of breast cancers that still lacks effective therapeutics. As a result, the early-stage detection of TNBCs is vital and will have huge significance in clinical practice. Driven by this need, we here report the design of highly crystalline antibody-conjugated multifunctional multicolor-luminescence nanosystems derived from the naturally available popular tropical fruits mangoes and prunes, which have the ability to detect breast cancer heterogeneity via the selective separation and accurate identification of TNBC and HER-2(+) or ER/PR(+) breast cancer cells selectively and simultaneously. The detailed synthesis and characterization of the multifunctional multicolor nanosystems derived from tropical fruits have been reported. Experimental results show that by changing the fruits multicolor-luminescence carbon dots (LCDs) can be developed, which is mainly due to the formation of highly crystalline nanodots with different heavy metal dopants and is also due to the presence of different types of surface functional group. Experimental data that are presented show that the multifunctional multicolor nanoprobe can be used for the highly selective and simultaneous capture of targeted TNBC and HER-2(+) or ER(+) breast cancer cells, and the capture efficiency can be as high as 98%. Reported data indicate that multicolor fluorescence imaging can be used for mapping heterogeneous breast cancer cells simultaneously and can distinguish targeted TNBC from non-targeted HER-2(+) or ER/PR(+) breast cancer. Our finding suggests the excellent potential of the design of multicolor nanosystems derived from natural fruits for detecting cancer heterogeneity in clinical practice.